Fora Capital, LLC Glaukos Corp Transaction History

Fora Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$76.4 - $96.33 $466,422 - $588,094	-6,105 Reduced 28.4%	15,391 $1.45 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $1.12 Million - $1.6 Million	18,741 Added 680.25%	21,496 $1.71 Million
Q3 2023 Nov 13, 2023	SELL	$69.23 - $79.09 $105,921 - $121,007	-1,530 Reduced 35.71%	2,755 $207,000
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $194,710 - $305,134	4,285 New	4,285 $305,000
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $235,886 - $294,555	5,036 New	5,036 $268,000
Q2 2021 Aug 16, 2021	SELL	$73.06 - $97.7 $105,717 - $141,371	-1,447 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$70.43 - $97.42 $229,953 - $318,076	-3,265 Reduced 69.29%	1,447 $121 Million
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $184,353 - $283,730	3,770 Added 400.21%	4,712 $354,000
Q3 2020 Nov 13, 2020	BUY	$37.23 - $50.97 $35,070 - $48,013	942 New	942 $47 Million

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.